Investments
68Portfolio Exits
10Funds
2Service Providers
1About +ND Capital
+ND Capital (NanoDimension) is a venture capital firm founded in 2002 that invests in disruptive technologies across the life, physical, and data sciences. Its core belief is that scientific disciplines will continue to converge and that some of the biggest breakthroughs will be based on this convergence. The firm invests across the United States and Europe, and through its teams in Silicon Valley, Switzerland, and the Cayman Islands, we can help our portfolio companies bridge the Atlantic to attract capital, talent, and business partners. +ND Capital has over $500M under management and is currently investing its $335M third fund.
Want to inform investors similar to +ND Capital about your company?
Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.
Expert Collections containing +ND Capital
Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.
Find +ND Capital in 1 Expert Collection, including Synthetic Biology.
Synthetic Biology
382 items
Latest +ND Capital News
Sep 19, 2023
Airna , a Cambridge, MA-based biotech company which specializes in RNA editing therapeutics, raised $30M in funding. The round was led by ARCH Venture Partners, with participation from ND Capital, Fast Track Initiative (FTI), Novalis, and Codon Capital. Led by CEO Kris Elverum, Airna is advancing RNA editing therapeutics. RNA editing targets diseases not accessible through other approaches with a medicine that can be re-dosed and manufactured. Co-founders Thorsten Stafforst (University of Tübingen) and Jin Billy Li (Stanford University), were the first to elucidate a therapeutic approach for precise editing of RNA. The company intends to use the funds to advance a pipeline of RNA editing therapeutics driven by its RNA editing platform, RESTORE+TM. Its first therapeutic program is a product candidate to treat the inherited genetic disease alpha-1 antitrypsin deficiency (AATD), as well as a pipeline of therapeutic candidates to address multiple diseases with high unmet need. Airna also has research operations in Tübingen, Germany. FinSMEs
+ND Capital Investments
68 Investments
+ND Capital has made 68 investments. Their latest investment was in AIRNA as part of their Seed VC on September 9, 2023.
+ND Capital Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
9/19/2023 | Seed VC | AIRNA | $30M | Yes | +ND Capital, ARCH Venture Partners, Codon Capital, Fast Track Initiative, and Novalis Innovative Flooring | 3 |
8/24/2023 | Unattributed VC | Opnovix | $4.5M | Yes | 1 | |
8/17/2023 | Series B | Lightcast Discovery | $49M | Yes | 1 | |
3/13/2023 | Series B | |||||
10/26/2022 | Series B - III |
Date | 9/19/2023 | 8/24/2023 | 8/17/2023 | 3/13/2023 | 10/26/2022 |
|---|---|---|---|---|---|
Round | Seed VC | Unattributed VC | Series B | Series B | Series B - III |
Company | AIRNA | Opnovix | Lightcast Discovery | ||
Amount | $30M | $4.5M | $49M | ||
New? | Yes | Yes | Yes | ||
Co-Investors | +ND Capital, ARCH Venture Partners, Codon Capital, Fast Track Initiative, and Novalis Innovative Flooring | ||||
Sources | 3 | 1 | 1 |
+ND Capital Portfolio Exits
10 Portfolio Exits
+ND Capital has 10 portfolio exits. Their latest portfolio exit was Crocus Technology on August 08, 2023.
Date | Exit | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Acquirer | Sources |
|---|---|---|---|---|---|
8/8/2023 | Acquired | 4 | |||
6/21/2022 | Acquired | 11 | |||
9/21/2021 | Acquired | 5 | |||
Date | 8/8/2023 | 6/21/2022 | 9/21/2021 | ||
|---|---|---|---|---|---|
Exit | Acquired | Acquired | Acquired | ||
Companies | |||||
Valuation | |||||
Acquirer | |||||
Sources | 4 | 11 | 5 |
+ND Capital Fund History
2 Fund Histories
+ND Capital has 2 funds, including NanoDimension II LP.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
1/1/2015 | NanoDimension II LP | Early-Stage Venture Capital | Closed | $150M | 1 |
3/27/2007 | NanoDimension LP |
Closing Date | 1/1/2015 | 3/27/2007 |
|---|---|---|
Fund | NanoDimension II LP | NanoDimension LP |
Fund Type | Early-Stage Venture Capital | |
Status | Closed | |
Amount | $150M | |
Sources | 1 |
+ND Capital Team
3 Team Members
+ND Capital has 3 team members, including current Founder, Chief Executive Officer, Aymeric Sallin.
Name | Work History | Title | Status |
|---|---|---|---|
Aymeric Sallin | Founder, Chief Executive Officer | Current | |
Name | Aymeric Sallin | ||
|---|---|---|---|
Work History | |||
Title | Founder, Chief Executive Officer | ||
Status | Current |
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
